Blood Cancer: Medical Treatments
Commons · Question 92958 · Tabled 20 Nov 2025 · Department of Health and Social Care · Official record
Answered 27 Nov 2025
Question
Asked by Andrew Rosindell
To ask the Secretary of State for Health and Social Care, what assessment has been made of the proportion of terminated NICE health technology appraisals that are for blood cancer treatments compared to other cancers.
Answer
Answered by Zubir Ahmed, 27 Nov 2025
Since August 2019, 31% of National Institute for Health and Care Excellence (NICE) technology appraisals for blood cancer treatments were terminated as the company withdrew from the NICE appraisal process. For the same period, 21% of appraisals for all ca...